公开(公告)号：US20100137228A2

公开(公告)日：2010-06-03

申请号：US12222492

申请日：2008-08-11

申请人： Tatsuji ENOKI ,  Hiroaki SAGAWA ,  Takanari TOMINAGA ,  Eiji NISHIYAMA ,  Nobuto KOYAMA ,  Takeshi SAKAI ,  Fu-Gong YU ,  Katsushige IKAI ,  Ikunoshin KATO

发明人： Tatsuji ENOKI ,  Hiroaki SAGAWA ,  Takanari TOMINAGA ,  Eiji NISHIYAMA ,  Nobuto KOYAMA ,  Takeshi SAKAI ,  Fu-Gong YU ,  Katsushige IKAI ,  Ikunoshin KATO

IPC分类号： A61K31/70 ,  A61K31/335

CPC分类号： A01N43/04 ,  A23L3/3472 ,  A23L3/3544 ,  A23L3/3562 ,  A23L33/105 ,  A61K31/341 ,  A61K31/7048

摘要： Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose represented by formula (1): foods, drinks, cosmetics, etc. containing as the active ingredient at least one member selected from the group consisting of the above-mentioned compound, its aldehyde, its hydrate and 2-O-methylated derivatives thereof and soluble sugar compounds containing the above compound. This compound also shows, for example, an apoptosis-inducing activity, a carcinostatic activity and inhibitory activities on the production of active oxygen, lipid peroxide radicals and NO, which makes it useful also as the active ingredient of antioxidants and preservatives.

摘要翻译： 用于治疗，改善或预防对由式（1）表示的3,6-脱水吡喃半乳糖敏感的疾病的药物组合物：含有作为活性成分的至少一种选自上述组分的组分的食品，饮料，化妆品等， 所述化合物，其醛，其水合物和2-O-甲基化衍生物以及含有上述化合物的可溶性糖化合物。 该化合物还显示例如细胞凋亡诱导活性，制癌活性和对活性氧，脂质过氧化物自由基和NO的产生的抑制活性，这使得它也可用作抗氧化剂和防腐剂的活性成分。

公开(公告)号：US20100048491A2

公开(公告)日：2010-02-25

申请号：US12222492

申请日：2008-08-11

申请人： Tatsuji ENOKI ,  Hiroaki SAGAWA ,  Takanari TOMINAGA ,  Eiji NISHIYAMA ,  Nobuto KOYAMA ,  Takeshi SAKAI ,  Fu-Gong YU ,  Katsushige IKAI ,  Ikunoshin KATO

发明人： Tatsuji ENOKI ,  Hiroaki SAGAWA ,  Takanari TOMINAGA ,  Eiji NISHIYAMA ,  Nobuto KOYAMA ,  Takeshi SAKAI ,  Fu-Gong YU ,  Katsushige IKAI ,  Ikunoshin KATO

IPC分类号： A61K31/70 ,  A61K31/335

CPC分类号： A01N43/04 ,  A23L3/3472 ,  A23L3/3544 ,  A23L3/3562 ,  A23L33/105 ,  A61K31/341 ,  A61K31/7048

摘要： Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose represented by formula (1): foods, drinks, cosmetics, etc. containing as the active ingredient at least one member selected from the group consisting of the above-mentioned compound, its aldehyde, its hydrate and 2-O-methylated derivatives thereof and soluble sugar compounds containing the above compound. This compound also shows, for example, an apoptosis-inducing activity, a carcinostatic activity and inhibitory activities on the production of active oxygen, lipid peroxide radicals and NO, which makes it useful also as the active ingredient of antioxidants and preservatives.